4//SEC Filing
Patel Ronil A. 4
Accession 0001140361-23-020662
CIK 0001228627other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 9:25 PM ET
Size
6.9 KB
Accession
0001140361-23-020662
Insider Transaction Report
Form 4
Patel Ronil A.
Chief Business Officer
Transactions
- Award
Common Stock
2023-04-24+20,000→ 42,304 total - Award
Employee Stock Option (right to buy)
2023-04-24+30,000→ 30,000 totalExercise: $5.35Exp: 2033-04-23→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of April 24, 2023.
- [F2]The option will vest with respect to 7,500 shares on April 24, 2024, with the balance vesting quarterly in twelve equal installments thereafter.
Documents
Issuer
Ocuphire Pharma, Inc.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001974660
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 9:25 PM ET
- Size
- 6.9 KB